PTEN蛋白缺失与中国前列腺癌患者根治术后生化复发风险关系的研究

doi:10.3969/j.issn.1007-3969.2015.08.006

中国癌症杂志 ›› 2015, Vol. 25 ›› Issue (8): 595-601.doi: 10.3969/j.issn.1007-3969.2015.08.006

PTEN蛋白缺失与中国前列腺癌患者根治术后生化复发风险关系的研究

王　涛，杨晓群，孙娟娟，甘华磊，王朝夫

复旦大学附属肿瘤医院病理科，复旦大学上海医学院肿瘤学系，上海 200032

出版日期:2015-08-30 发布日期:2015-12-14
通信作者: 王朝夫　E-mail：wangchaofu@126.com

PTEN protein loss is associated with an increased risk of recurrence in Chinese patients after prostatectomy for clinically localized prostate cancer

WANG Tao, YANG Xiaoqun, SUN Juanjuan, GAN Hualei, WANG Chaofu

Department of Pathology, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China

Published:2015-08-30 Online:2015-12-14
Contact: WANG Chaofu E-mail: wangchaofu@126.com

摘要/Abstract

摘要： 背景与目的：张力蛋白同源第10号染色体缺失的磷酸酶基因(phosphatase and tensin homolog deleted on chromosome 10，PTEN)缺失是西方国家前列腺癌中最常见的基因异常之一，与肿瘤的进展、预后均有一定相关性。鉴于前列腺癌的异质性，不同地区、人群间其基因表达谱存在广泛差异，本研究主要探讨PTEN蛋白缺失在中国前列腺癌患者中的发生率以及与生化复发的相关性。方法：选取2006—2011年225例局限性前列腺癌并采取根治切除术的患者为研究对象，回顾性收集所有患者的临床病理资料，包括确诊时年龄、血清前列腺特异性抗原(prostate-specific antigen，PSA)值、Gleason分级评分、TNM分期、手术切缘和术后生化复发与否及时间。将225例局限性前列腺癌根治切除标本的肿瘤组织及癌旁组织制成组织芯片(tissue microarray，TMA)，采用免疫组织化学技术检测PTEN蛋白在肿瘤及癌旁组织中的表达。采用χ²检验分析前列腺癌组织中PTEN蛋白缺失与患者临床病理特征的相关性。运用Kaplan-Meier生存分析模型、Cox比例风险模型分析PTEN蛋白缺失及患者临床病理特征与生化复发的关系。结果：前列腺癌患者中PTEN蛋白缺失率为15%(33/217)，且存在PTEN蛋白缺失的前列腺癌患者其确诊时血清PSA值(P=0.030)及年龄(P=0.009)要显著高于PTEN表达的前列腺癌患者。单因素生存分析显示，PTEN表达情况(P=0.013 1)、确诊时血清PSA值(P=0.000 4)和Gleason分级评分(P=0.019 8)与前列腺癌患者的生化复发相关。Cox多因素分析结果表明，PTEN蛋白表达情况(HR=0.536，P=0.044)、确诊时血清PSA值(HR=1.879，P=0.001)和Gleason分级评分(HR=1.361，P=0.030)为前列腺癌患者生化复发的独立预后因素。结论：PTEN蛋白表达情况是局限性前列腺癌患者根治术后生化复发的独立预后因素，检测PTEN蛋白有望改善根治术后前列腺癌患者的管理及指导进一步治疗。

关键词: 前列腺肿瘤, 张力蛋白同源第10号染色体缺失的磷酸酶基因, 预后, 生化复发, 免疫组织化学

Abstract: Background and purpose: Loss of the tumor suppressor phosphatase and tensin homolog deleted on chromosome 10 (PTEN) is one of the most common somatic genetic aberrations in prostate cancer in Western countries and is frequently associated with tumor progression and poor prognosis. This study aimed to investigate the frequency of PTEN protein loss in Chinese prostate cancer patients and to determine its association with the biochemical recurrence of prostate cancer. Methods: The data from 225 diagnosed localized prostate cancer patients with radical prostatectomy from 2006 to 2011 were collected retrospectively, including patient’s age at diagnosis, prostate-specific antigen (PSA) level at diagnosis, Gleason score, clinical stage, surgical margin, and time to biochemical recurrence or not. This study performed PTEN protein immunohistochemistry on tissue microarrays, which were made from 225 Chinese prostate cancer patients mentioned above, treated by radical prostatectomy with one case including 2 cancer spots and 2 adjacent normal gland spots. Correlations of PTEN loss with clinicopathological features were analyzed using χ² test. Kaplan-Meier survival model and Cox proportional hazards regression model were used to evaluate the predictive role of PTEN protein expression and patient characteristics for biochemical recurrence. Results: PTEN protein loss was observed in 15% of the patients and was associated with increased preoperative PSA levels (P=0.03) and old age (P=0.009). In univariate Kaplan–Meier analysis, the factors associated with the biochemical recurrence of prostate cancer included PSA levels (P=0.000 4), Gleason sum (P=0.019 8), and PTEN status (P=0.013 1). In multivariable Cox regression analysis, PTEN expression (HR=0.536, P=0.044), PSA levels (HR=1.879, P=0.001), and Gleason score (HR=1.361, P=0.03) were significant in predicting biochemical recurrence of prostate cancer. Conclusion: PTEN protein loss is associated with an increased risk of recurrence, independent of known clinicopathological factors.

Key words: Prostate cancer, Phosphatase and tensin homolog deleted on chromosome 10, Prognosis, Biochemical recurrence, Immunohistochemistry

王　涛,杨晓群,孙娟娟,等. PTEN蛋白缺失与中国前列腺癌患者根治术后生化复发风险关系的研究[J]. 中国癌症杂志, 2015, 25(8): 595-601.

WANG Tao, YANG Xiaoqun, SUN Juanjuan, et al. PTEN protein loss is associated with an increased risk of recurrence in Chinese patients after prostatectomy for clinically localized prostate cancer[J]. China Oncology, 2015, 25(8): 595-601.

[1]	林艺, 王策, 康勋, 康庄, 陈峰, 江波, 李文斌. 胶质母细胞瘤复发相关基因的筛选、表达和临床预后分析[J]. 中国癌症杂志, 2022, 32(1): 13-23.
[2]	徐　然, 王馨悦, 冯麟媛, 韩安娜, 王艺璇, 杨万山, 刘　超 . 神经胶质瘤中NCAPD2的表达水平及生物学意义[J]. 中国癌症杂志, 2021, 31(9): 789-798.
[3]	马祎菲, 梁新军, 魏少忠 . 炎症与免疫指标在可切除性结直肠癌中的预后价值[J]. 中国癌症杂志, 2021, 31(9): 845-851.
[4]	雷雅洁, 高　毅, 王治洁, 程　玺, 杨雨菲, 周宏宇, 陈丽华, 陈伊新, 李浩然, 李子庭, 吴小华 . 早期卵巢癌（Ⅰ C ~ⅡA）患者腹主动脉旁淋巴结清扫术对预后影响的临床分析[J]. 中国癌症杂志, 2021, 31(8): 740-745.
[5]	高鹤丽, 徐　近, 虞先濬. 分化好的胃肠胰神经内分泌瘤G3的诊治新进展[J]. 中国癌症杂志, 2021, 31(7): 567-573.
[6]	巩润泽, 胡海燕. CCL2在骨肉瘤组织中的表达及其临床意义[J]. 中国癌症杂志, 2021, 31(6): 455-459.
[7]	彭子珊, 孔　辉, 鲍　真, 赵红杏, 刘　鑫, 卢韶华. 83例多发肺腺癌患者的临床病理学特征分析[J]. 中国癌症杂志, 2021, 31(5): 408-418.
[8]	肖　锋, 肖静文, 邵建国, 陈丽燕, 顾春燕 . PD-1在肝细胞癌肿瘤浸润淋巴细胞中的表达及与预后的相关性[J]. 中国癌症杂志, 2021, 31(5): 419-427.
[9]	中国抗癌协会泌尿男生殖系统肿瘤专业委员会前列腺癌学组. 前列腺癌筛查中国专家共识（2021年版）[J]. 中国癌症杂志, 2021, 31(5): 435-440.
[10]	王春建 , 聂　刚 , 毛　艳 . TRIP6在乳腺癌中的作用及其机制研究[J]. 中国癌症杂志, 2021, 31(3): 161-169.
[11]	武元元 , 王　军 , 刘勤江 , 张　明 . 甲状腺未分化癌的预后因素分析及治疗决策[J]. 中国癌症杂志, 2021, 31(3): 212-220.
[12]	冯润林 , 华　结 , 奎　翔 , 李如懿 , 易晓佳 , 王　燕 , 陶燕萍 . 转移性心包黏液样脂肪肉瘤1例报道并文献复习[J]. 中国癌症杂志, 2021, 31(3): 227-230.
[13]	杨柳松, 祝迎锋, 唐剑敏 . 上皮样胶质母细胞瘤10例报告并文献复习[J]. 中国癌症杂志, 2021, 31(2): 114-120.
[14]	丁平安, 张志栋, 杨沛刚, 林叶成, 田　园, 徐校胜, 吴　娟, 刘　颖, 郭洪海, 刘　洋, 王　冬, 檀碧波, 李　勇, 赵　群 . 胃癌脑膜转移的临床病理学特征及预后分析[J]. 中国癌症杂志, 2021, 31(2): 126-135.
[15]	周宏宇, 李浩然, 程　玺, 陈丽华, 杨雨菲, 常　彬 . 11例卵巢高钙血症型小细胞癌临床分析并文献复习[J]. 中国癌症杂志, 2021, 31(2): 136-142.

PTEN蛋白缺失与中国前列腺癌患者根治术后生化复发风险关系的研究

PTEN protein loss is associated with an increased risk of recurrence in Chinese patients after prostatectomy for clinically localized prostate cancer

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价